# The Food and Drug Administration (FDA) intends to award a sole source contract to the Reagan-Udall Foundation for the FDA (RUF) to support execution of its ts congressionally mandated regulatory mission across 16 project areas

Canonical: https://abierto.us/opportunities/fdassoc136354

- Solicitation number: FDASSOC136354
- Notice type: Special notice
- Status: Closed. Deadline was September 21, 2026 at 1:30 PM EDT
- Department: Department of Health and Human Services
- Agency: Food and Drug Administration
- Contracting office: FDA Negotiated Contracts Branch (752401)
- NAICS: 541618 Other Management Consulting Services
- Product or service code: R799 Other Management Support Services
- Place of performance: Silver Spring, Maryland
- County: Montgomery County (FIPS 24031). https://abierto.us/counties/montgomery-county-md-24031
- City: Silver Spring. https://abierto.us/cities/silver-spring-md-2472450
- First posted: September 14, 2026
- Last posted: September 14, 2026
- SAM.gov: https://sam.gov/workspace/contract/opp/43375f32d074401ebb2bb3897fc0cad9/view

## Description

The Food and Drug Administration (FDA) intends to award a sole source contract to the Reagan-Udall Foundation for the FDA (RUF) to support execution of its congressionally mandated regulatory mission across 16 project areas addressing high-priority regulatory science gaps and public health challenges. The work — spanning structured stakeholder engagement, independent scientific convening, and landscape research — is a prerequisite to FDA's ability to develop sound regulatory frameworks and fulfill statutory obligations.

Each project area targets a specific gap where FDA cannot act without the scientific foundation, stakeholder input, or evidence infrastructure this contract provides. The contract is framed as a high-value investment: the cost of inaction — measured in delayed regulatory frameworks, preventable harm, and eroded public trust — exceeds the cost of the engagement.

See Attachment for Intent to Sole Source Posting

See Attachment for Draft Statement of Work

## Attachments

- [Intent to Sole Source DRAFT 9 14 2026 1152 AM.pdf](https://abierto.us/files/5f8d760394f1844d082a0e555357596b3dfe1ecdd9e6025af050a04df405d4eb/Intent%20to%20Sole%20Source%20DRAFT%209%2014%202026%201152%20AM.pdf)
- [STATEMENT OF WORK DRAFT 9 14 2026.pdf](https://abierto.us/files/a82f918f1e2bfdad09626dbcc4d6d13452506181246f78b0019a47fac5b4474f/STATEMENT%20OF%20WORK%20DRAFT%209%2014%202026.pdf)

## Publications

- September 14, 2026: Special notice, due September 21, 2026 at 1:30 PM EDT. Notice 43375f32d074401ebb2bb3897fc0cad9. https://sam.gov/workspace/contract/opp/43375f32d074401ebb2bb3897fc0cad9/view

## Points of contact

- Howard Yablon, howard.yablon@fda.hhs.gov
- Ian Weiss, ian.weiss@fda.hhs.gov

---
Source: SAM.gov Contract Opportunities bulk extract. Confirm deadlines on SAM.gov before responding. Cite https://abierto.us/opportunities/fdassoc136354.